🔎 Trials Near Me

Home › Ventricular Premature Complexes › NCT06060548

Role of Novel ILR in the Management of PVCs

RecruitingObservational study

Role of a Novel Implantable Loop Recorder in the Management of Premature Ventricular Contractions

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Patients \> 18 years of age
* Have a Medtronic LINQ II ILR
* Willing and able to give written informed consent

Exclusion Criteria:

* History of myocardial infarction
* Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronary angiography or Computed tomography angiography (CTA).
* History of cardiac arrest
* With existing implantable defibrillators
* Currently pregnant

About the study

This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.

What is being tested

Sponsor: Kansas City Heart Rhythm Research Foundation · Participants: 50 · Started: Apr 20, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT06060548

Locations in the U.S.

KansasKansas City Heart Rhythm Institute - Roe Clinic, Overland Park
Overland Park Regional Medical Center, Overland Park
MissouriCenterpoint Medical Center, Independence
Centerpoint Medical Center Clinic, Independence
Research Medical Center, Kansas City
Research Medical Center Clinic, Kansas City

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.